Aetna is taking the business side of a health problem and saying that if you have MS and typical treatments don't work, better buy your tombstone because we aren't going to pay for other treatments.
Take a look at what Questcor says about the group of patients for which this product is for.
They never really said that the product was going to save people with MS.
It is for those which have usually tried known treatment, but had less than stellar results.
Sure this in and of itslef isn't a glowing review for the product, but let's say you have a disease and go through the typical treatment. Unfortunately the treatment doesn't take for you. What do you do at this time? Accept Death?
Now, if the company marketed the product as the best thing in the world for MS patients, than I would totally agree with your assessment of where the stock is headed.
News 
Market Data 
Discover 
AI
